Living Well With Advanced Breast Cancer

Ohio State University Comprehensive Cancer Center50 enrolled

Overview

This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.

PRIMARY OBJECTIVES: I. Assess acceptability of current LWABC model. II. Conduct a comprehensive review of participants' medical history, treatment records, and demographic data. III. Explore differences in survivorship care engagement across four distinct cohorts. OUTLINE: This is an observational study. Participants complete a survey and a semi-structured interview on study.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Advanced Breast Carcinoma Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Breast Carcinoma

Interventions

Non-Interventional StudyOTHER

Non-interventional study

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * \* COHORT 1: * Diagnosis of stage 4 metastatic breast cancer within the past 5 years * Never been referred to the LWABC * Adults age ≥ 18 years * COHORT 2: * Diagnosis of stage 4 metastatic breast cancer within the past 5 years * Have cancelled an appointment with the LWABC * Adults age ≥ 18 years * COHORT 3: * Been seen in the Medical Oncology Clinic at Stephanie Spielman Comprehensive Breast Center (SSCBC) within the past 5 years * Completed an appointment with the LWABC * Adults age ≥ 18 years * COHORT 4: * Caregivers for ABC patients * Adults age ≥ 18 years Exclusion Criteria: * Patients who cannot provide own informed consent

Locations (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

RECRUITING

Outcomes

Primary Outcomes

Acceptability of current LWABC (Living Well with Advanced Breast Cancer) model

Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Survey items will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

Time frame: Up to study completion, up to 1 day

Participant medical history, treatment records, and demographic data

Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Survey items including demographic information and disease characteristics will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

Time frame: Up to study completion, up to 1 day

Differences in survivorship care engagement across four distinct cohorts

Will utilize a thematic inductive analysis approach to compare and contrast themes across cohorts. Themes will be compared across each cohort to identify survivorship care needs that will be translated into intervention components for the ABC survivorship program. Survey items will be summarized by cohort. Means, standard deviations, medians and ranges will be calculated for continuous variables and frequency, percents and 95% confidence intervals will be calculated for categorical variables.

Time frame: Up to study completion, up to 1 day

Central Contacts

The Ohio State University Comprehensive Cancer Center

CONTACT

800-293-5066 OSUCCCClinicaltrials@osumc.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.